Neoadjuvant Chemo-IO Promising in Borderline Resectable Pancreatic Cancer

(MedPage Today) -- SAN DIEGO -- A preoperative combination of chemotherapy and immunotherapy (IO) appeared safe and effective for borderline resectable pancreatic cancer in a small pilot study, a researcher reported here. In the phase I/II trial...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news